-
Iran fires new wave of missiles at Israel after denying Trump talks
-
Manila's jeepney drivers struggle as Mideast war sends diesel cost soaring
-
The contenders vying to be next Danish leader
-
India's historic haveli homes caught between revival and ruin
-
Denmark votes in close election, outgoing PM tipped to win
-
N. Korea's Kim vows 'irreversible' nuclear status, warns Seoul of 'merciless' response
-
Pressure on Italy as play-off hopefuls eye 2026 World Cup
-
Malinin and Sakamoto seek solace at figure skating worlds as Olympic champions absent
-
'Perfect Japan' posts spark Gen Z social media backlash
-
Asian stocks rise on Trump U-turn but unease sees oil bounce
-
Pistons halt Lakers streak while Spurs, Thunder win
-
Silence not an option, says Canadian Sikh activist after fresh threats
-
Rennie shakes up All Blacks backroom team as 2027 World Cup looms
-
Australia, EU agree to sweeping new trade pact after eight years
-
Too old? The 92-year-old US judge handling Maduro case
-
Australia, EU agree sweeping new trade pact
-
Sinner, Sabalenka march on in Miami as more seeds crash out
-
US social media addiction trial jury struggles for consensus
-
EU 'concerned' by reports Hungary leaked information to Russia
-
EU chief meets Australian PM as trade talks enter 'last mile'
-
Israel pounds south Beirut, says captured Hezbollah members
-
EU chief to meet Australian PM as trade talks enter 'last mile'
-
Champion Mensik, Medvedev dumped out of Miami Open
-
Jury at US social media addiction trial reports 'difficulty' in finding consensus
-
Stokes eager to lead England recovery after 'hardest period of captaincy'
-
Venezuela protesters demand end to 'hunger' level wages
-
Eight people arrested in Brazil for 'brutal' attack on capybara
-
Audi Q9 – how likely is it to become a reality?
-
Oil slides, stocks rebound on Trump's Iran remarks
-
On Iran, Trump executes his most spectacular U-turn yet
-
Trump announces 'very good' Iran talks denied by Tehran
-
Bill Cosby ordered to pay $19m over sex abuse claim
-
Dodgers eye 'threepeat' as new MLB season welcomes robot umpires
-
Dacia Striker: Stylish and sturdy?
-
Skoda Peaq: New all-electric seven-seater
-
Medvedev ousted by Cerundolo at Miami Open
-
Runway collision kills two pilots at New York airport
-
Italian voters reject Meloni's reforms in referendum blow
-
Bosnian truckers blocked EU freight terminals for a day over visa rules
-
Colombia military aircraft crashes with 125 aboard, many feared dead
-
Rip-offs at the petrol pump?
-
Shakira to wrap up world tour with Madrid residency
-
World gave Israel 'licence to torture Palestinians': UN expert
-
Colombia says 80 troops on crashed aircraft, many feared dead
-
France turns to 2027 race to succeed Macron
-
New Mercedes GLC electric
-
Namibia rejects Starlink licence request
-
Ex-model questioned in France over scout with Epstein links
-
UK sending air defence systems to Gulf: PM
-
Trump administration seeks to ease oil fears but industry wary
US expands access to abortion pills through pharmacies
Retail pharmacies in the United States will be permitted to sell abortion pills, health officials said Tuesday, a move that could significantly expand access to the procedure after last year's landmark Supreme Court ruling that overturned federal abortion rights.
Regulatory changes announced by the Food and Drug Administration mean that mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.
A doctor's prescription will be needed to obtain the pills, which were previously only available from a few mail-order pharmacies or certified doctors and clinics.
Demand for abortion pills has risen since the conservative-dominated Supreme Court made a landmark ruling last June that overturned Roe v. Wade, a 1973 case that had guaranteed women's right to an abortion for half a century.
Abortion pills are already used in more than half of US procedures to terminate a pregnancy, experts say, and they have increasingly become a focus in the political and legal battle for abortion rights since the Supreme Court's controversial decision.
Pharmacies will need to receive certification to dispense the drug, while patients will need to complete a consent form.
The FDA's decision was welcomed by the American Civil Liberties Union.
"We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency's needless burdens on mifepristone patients," said Julia Kaye of the ACLU's Reproductive Freedom Project.
Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List slammed the decision.
"The Biden administration has once again proved that it values abortion industry profits over women's safety and unborn children's lives," Dannenfelser said in a statement.
D.Qudsi--SF-PST